Another alteration observed was expansion, not higher than 20%, of some TCR-Vβ families in the EBV response in this group of patients; for instance, the frequency of Vβ5.3+ and Vβ4+ CD4+ T cells in one patient at stage 1 and in 1 patient with lymphoma, respectively. This evidence concerns the gene CD4 and lymphoma.